The economic consequences of generic substitution for antiepileptic drugs in a public payer setting: the case of lamotrigine. [electronic resource]
Producer: 20071220Description: 216-25 p. digitalISSN:- 1093-507X
- Adult
- Anticonvulsants -- economics
- Cost Savings
- Drug Costs -- statistics & numerical data
- Drug Prescriptions
- Drug Utilization -- economics
- Drugs, Generic -- economics
- Epilepsy -- drug therapy
- Excitatory Amino Acid Antagonists
- Female
- Follow-Up Studies
- Humans
- Insurance, Health, Reimbursement -- economics
- Lamotrigine
- Male
- Prospective Payment System -- economics
- Quebec
- Retrospective Studies
- Triazines -- economics
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.